Cargando…
Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth
(1) Background: Regular contact with a medication therapy management (MTM) pharmacist is shown to improve patients’ understanding of their condition; however, continued demonstration of the value of a pharmacist delivered comprehensive medication review (CMR) using enhanced MTM services via teleheal...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296452/ https://www.ncbi.nlm.nih.gov/pubmed/34207164 http://dx.doi.org/10.3390/ijerph18126560 |
_version_ | 1783725642046504960 |
---|---|
author | Bingham, Jennifer M. Stanislaw, Jennifer Warholak, Terri Scovis, Nicole Axon, David R. Turgeon, Jacques Marupuru, Srujitha |
author_facet | Bingham, Jennifer M. Stanislaw, Jennifer Warholak, Terri Scovis, Nicole Axon, David R. Turgeon, Jacques Marupuru, Srujitha |
author_sort | Bingham, Jennifer M. |
collection | PubMed |
description | (1) Background: Regular contact with a medication therapy management (MTM) pharmacist is shown to improve patients’ understanding of their condition; however, continued demonstration of the value of a pharmacist delivered comprehensive medication review (CMR) using enhanced MTM services via telehealth is needed. The study aimed to describe a pilot program designed to improve type 2 diabetes mellitus (T2DM) management through enhanced condition specific MTM services. (2) Methods: This retrospective study included patients with T2DM aged 40–75 years who received a pharmacist-delivered CMR between January and December 2018. An evaluation of glycosylated hemoglobin (HbA1c) values 3 months pre- and post-CMR was performed. Wilcoxon signed-rank and chi-square tests were used. (3) Results: Of 444 eligible patients, a majority were female (58%) with a median age of 70 years. Median HbA1c values post-CMR were lower than pre-CMR (median 7.1% range 4.5–13.6; median 7.4% range 4.5–13.9, respectively; p = 0.009). There were fewer participants with HbA1c >9% post-CMR (n = 66) than pre-CMR (n = 80; p < 0.001) and more with HbA1C <6.5% post-CMR (n = 151) than pre-CMR (n = 130; p < 0.001). (4) Conclusion: This program evaluation highlighted the value of an enhanced condition specific MTM service via telehealth. Patients had improved HbA1c values three months after receiving a single pharmacist delivered CMR. |
format | Online Article Text |
id | pubmed-8296452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82964522021-07-23 Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth Bingham, Jennifer M. Stanislaw, Jennifer Warholak, Terri Scovis, Nicole Axon, David R. Turgeon, Jacques Marupuru, Srujitha Int J Environ Res Public Health Article (1) Background: Regular contact with a medication therapy management (MTM) pharmacist is shown to improve patients’ understanding of their condition; however, continued demonstration of the value of a pharmacist delivered comprehensive medication review (CMR) using enhanced MTM services via telehealth is needed. The study aimed to describe a pilot program designed to improve type 2 diabetes mellitus (T2DM) management through enhanced condition specific MTM services. (2) Methods: This retrospective study included patients with T2DM aged 40–75 years who received a pharmacist-delivered CMR between January and December 2018. An evaluation of glycosylated hemoglobin (HbA1c) values 3 months pre- and post-CMR was performed. Wilcoxon signed-rank and chi-square tests were used. (3) Results: Of 444 eligible patients, a majority were female (58%) with a median age of 70 years. Median HbA1c values post-CMR were lower than pre-CMR (median 7.1% range 4.5–13.6; median 7.4% range 4.5–13.9, respectively; p = 0.009). There were fewer participants with HbA1c >9% post-CMR (n = 66) than pre-CMR (n = 80; p < 0.001) and more with HbA1C <6.5% post-CMR (n = 151) than pre-CMR (n = 130; p < 0.001). (4) Conclusion: This program evaluation highlighted the value of an enhanced condition specific MTM service via telehealth. Patients had improved HbA1c values three months after receiving a single pharmacist delivered CMR. MDPI 2021-06-18 /pmc/articles/PMC8296452/ /pubmed/34207164 http://dx.doi.org/10.3390/ijerph18126560 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bingham, Jennifer M. Stanislaw, Jennifer Warholak, Terri Scovis, Nicole Axon, David R. Turgeon, Jacques Marupuru, Srujitha Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth |
title | Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth |
title_full | Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth |
title_fullStr | Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth |
title_full_unstemmed | Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth |
title_short | Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth |
title_sort | assessment of glycosylated hemoglobin outcomes following an enhanced medication therapy management service via telehealth |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296452/ https://www.ncbi.nlm.nih.gov/pubmed/34207164 http://dx.doi.org/10.3390/ijerph18126560 |
work_keys_str_mv | AT binghamjenniferm assessmentofglycosylatedhemoglobinoutcomesfollowinganenhancedmedicationtherapymanagementserviceviatelehealth AT stanislawjennifer assessmentofglycosylatedhemoglobinoutcomesfollowinganenhancedmedicationtherapymanagementserviceviatelehealth AT warholakterri assessmentofglycosylatedhemoglobinoutcomesfollowinganenhancedmedicationtherapymanagementserviceviatelehealth AT scovisnicole assessmentofglycosylatedhemoglobinoutcomesfollowinganenhancedmedicationtherapymanagementserviceviatelehealth AT axondavidr assessmentofglycosylatedhemoglobinoutcomesfollowinganenhancedmedicationtherapymanagementserviceviatelehealth AT turgeonjacques assessmentofglycosylatedhemoglobinoutcomesfollowinganenhancedmedicationtherapymanagementserviceviatelehealth AT marupurusrujitha assessmentofglycosylatedhemoglobinoutcomesfollowinganenhancedmedicationtherapymanagementserviceviatelehealth |